Difference between revisions of "Sunitinib"

Sunitinib (view source)

10 bytes added , 19:57, 8 November 2018

no edit summary

48,475

edits

Revision as of 13:34, 9 August 2018 (view source) Michael (talk \| contribs) ← Older edit		Latest revision as of 19:57, 8 November 2018 (view source) Michael (talk \| contribs)
Line 1:		Line 1:
	'''Sunitinib''' (marketed with the brand name ''Sutent'') is a [[tyrosine kinase inhibitor]] used to treat [[renal cell carcinoma]] (RCC).		'''Sunitinib''' (marketed with the brand name ''Sutent'' by Pfizer) is a [[tyrosine kinase inhibitor]] used to treat [[renal cell carcinoma]] (RCC).

	In RCC acts on:<ref>{{Cite journal \| last1 = Toon \| first1 = CW. \| last2 = Hasovits \| first2 = C. \| last3 = Paik \| first3 = J. \| last4 = Field \| first4 = M. \| last5 = Chou \| first5 = A. \| last6 = Hugh \| first6 = TJ. \| last7 = Pavlakis \| first7 = N. \| last8 = Gill \| first8 = AJ. \| title = Skin rash, a kidney mass and a family mystery dating back to World War II. \| journal = Med J Aust \| volume = 201 \| issue = 1 \| pages = 58-60 \| month = Jul \| year = 2014 \| doi = \| PMID = 24999901 }}</ref>		In RCC acts on:<ref>{{Cite journal \| last1 = Toon \| first1 = CW. \| last2 = Hasovits \| first2 = C. \| last3 = Paik \| first3 = J. \| last4 = Field \| first4 = M. \| last5 = Chou \| first5 = A. \| last6 = Hugh \| first6 = TJ. \| last7 = Pavlakis \| first7 = N. \| last8 = Gill \| first8 = AJ. \| title = Skin rash, a kidney mass and a family mystery dating back to World War II. \| journal = Med J Aust \| volume = 201 \| issue = 1 \| pages = 58-60 \| month = Jul \| year = 2014 \| doi = \| PMID = 24999901 }}</ref>